Back to Search Start Over

Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention.

Authors :
Peterson, Pamela N.
Varosy, Paul D.
Heidenreich, Paul A.
Yongfei Wang
Dewland, Thomas A.
Curtis, Jeptha P.
Go, Alan S.
Greenlee, Robert T.
Magid, Pavid J.
Normand, Sharon-Lise T.
Masoudi, Frederick A.
Source :
JAMA: Journal of the American Medical Association; 5/15/2013, Vol. 309 Issue 19, p2025-2034, 10p
Publication Year :
2013

Abstract

Importance Randomized trials of implantable cardioverter-defibrillators (ICDs) for primary prevention predominantly used single-chamber devices. In clinical practice, patients often receive dual-chamber ICDs, even without clear indications for pacing. The outcomes of dual- vs single-chamber devices are uncertain. Objective To compare outcomes of single- and dual-chamber ICDs for primary prevention of sudden cardiac death. Design, Setting, and Participants Retrospective cohort study of admissions in the National Cardiovascular Data Registry's (NCDR) ICD registry from 2006-2009 that could be linked to Centers for Medicare & Medicaid Services fee-for-service Medicare claims data. Patients were included if they received an ICD for primary prevention and did not have a documented indication for pacing. Main Outcomes and Measures Adjusted risks of 1-year mortality, all-cause read-mission, heart failure readmission, and device-related complications within 90 days were estimated with propensity-score matching based on patient, clinician, and hospital factors. Results Among 32 034 patients, 12 246(38%) received a single-chamber device and 19 788 (62%) received a dual-chamber device. In a propensity-matched cohort, rates of complications were lower for single-chamber devices (3.51 % vs 4.72%; P< .001; risk difference, -1.20 [95% CI, -1.72 to -0.69]), but device type was not significantly associated with 1 -year mortality (unadjusted rate, 9.85% vs 9.77%; hazard ratio [HR], 0.99 [95% CI, 0.91 to 1.07]; P=.79), 1-year all-cause hospitalization (unadjusted rate, 43.86% vs 44.83%; HR, 1.00 [95% CI, 0.97-1.04]; P=.82), or hospitalization for heart failure (unadjusted rate, 14.73% vs 15.38%; HR, 1.05 [95% CI, 0.99-1.12]; P=.19). Conclusions and Relevance Among patients receiving an ICD for primary prevention without indications for pacing, the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1 -year mortality and hospitalization outcomes. Reasons for preferentially using dual-chamber ICDs in this setting remains unclear. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00987484
Volume :
309
Issue :
19
Database :
Complementary Index
Journal :
JAMA: Journal of the American Medical Association
Publication Type :
Academic Journal
Accession number :
87602660
Full Text :
https://doi.org/10.1001/jama.2013.4982